Children with nocturnal enuresis and attention deficit hyperactivity disorder: A separate entity?

Introduction There is ongoing debate about whether nocturnal enuresis (NE) is affected by the presence of attention deficit hyperactivity disorder (ADHD) in children. Clarifying this relationship could categorize them as a separate entity, potentially requiring a different management from enuretic children without ADHD. Aims To study whether (1) children with ADHD exhibited greater severity of enuresis and associated voiding symptoms compared with children without ADHD, (2) whether there was a difference in enuretic response to treatment between children with/without ADHD, (3) whether previously prescribed medication for ADHD affected severity of enuresis or voiding symptoms, and response to treatment. Methods Data on all consecutive children seen with primary NE and ADHD and age- and gender-matched children with NE without ADHD over the course of 2 years were extracted from our database. Controls were identified using a random number generator to choose patients within each age/gender group. Changes in Dysfunctional Voiding Scoring System (DVSS) and Bristol scores were assessed before and after treatment for NE using repeated measures ANOVAs. Number of weekly wet nights was compared between the groups before and after the treatment of enuresis. Children with more than a 50% decrease in number of wet nights per week were categorized as responding to treatment. Results Compared with controls, ADHD children (N = 95) had significantly more severe voiding symptoms, NE and constipation (Table). No significant differences were found between children on ADHD medication (63.2%) and those who were not on ADHD medication (36.8%) on any of the demographic and pre-treatment clinical parameters. Similar enuretic response rates to behavioral modification alone were seen in both study (13.5%) and control (12.8%) groups (p = 0.73). Response to pharmacological treatment was seen in nine patients with ADHD (42.9%) and in six (20.7%) controls, with pharmacological intervention being significantly more effective than behavioral modification for patients with ADHD (p = 0.012). Additionally, no difference was found between ADHD patients on and off ADHD medication in terms of response to enuresis treatment. Conclusion TableDemographics and clinical characteristics among children with primary NE and ADHD (study group) and children with NE without ADHD (control group). Study group (N = 95) Control group (N = 95) p Gender, male/female 67/28 67/28 – Age, years a Mean ± standard deviation (range). 8.87 ± 2.42 (5–16) 8.92 ± 2.49 (5–16) 0.91 Race 0.28 African American N = 44 (46.4%) N = 50 (52.6%) Caucasian N = 33 (34.7%) N = 23 (24.2%) Other N = 18 (18.9%) N = 22 (23.2%) Total number of clinic visits a Mean ± standard deviation (range). 2.19 ± 1.40 (1–8) 2.08 ± 1.26 (1–7) 0.59 DVSS score a Mean ± standard deviation (range). 11.53 ± 4.53 (0–21) 9.84 ± 3.82 (1–20) 0.008 Number of wet nights per week a Mean ± standard deviation (range). 6.26 ± 1.54 (1–7) 5.74 ± 2.05 (1–7) 0.047 Bristol score a Mean ± standard deviation (range). 2.92 ± 0.95 (1–6) 3.23 ± 0.87 (2–6) 0.024 Bold value represents statistically significant p < 0.05. a Mean ± standard deviation (range). Open table in a new tab